Regulation of thrombin activity by antithrombin and heparin.
about
Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?Beyond heparinization: design of highly potent thrombin inhibitors suitable for surface couplingAn update on recent patents on thrombin inhibitors (2010 - 2013)Synthesis of thrombin-inhibiting heparin mimetics without side effects.Thrombocytopenia in Dengue: Interrelationship between Virus and the Imbalance between Coagulation and Fibrinolysis and Inflammatory Mediators.Lower-extremity functional electrical stimulation decreases platelet aggregation and blood coagulation in persons with chronic spinal cord injury: a pilot study.Hydration structure of antithrombin conformers and water transfer during reactive loop insertionAntithrombotic and profibrinolytic activities of eckol and dieckol.Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cellsStructural insights into the unique inhibitory mechanism of the silkworm protease inhibitor serpin18.Identification of tissue-type plasminogen activator-specific plasminogen activator inhibitor-1 mutants. Evidence that second sites of interaction contribute to target specificity.Elucidating the specificity of non-heparin-based conformational activators of antithrombin for factor Xa inhibition.Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin.Comparison of biological activities of human antithrombins with high-mannose or complex-type nonfucosylated N-linked oligosaccharides.Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement.Glycosaminoglycans facilitate procathepsin B activation through disruption of propeptide-mature enzyme interactions.Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin.Identification and function probing of an antithrombin IIIβ conformation-specific antibody.Inhibition or activation of Apert syndrome FGFR2 (S252W) signaling by specific glycosaminoglycans.Structural and energetic characteristics of the heparin-binding site in antithrombotic protein C.Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.Thrombosis and the pharmacology of antithrombotic agents.Click-coated, heparinized, decellularized vascular graftsInactivation of papain by antithrombin due to autolytic digestion: a model of serpin inactivation of cysteine proteinases.Conformational changes in thrombin when complexed by serpins.Helix D elongation and allosteric activation of antithrombin.Stable complex formation between serine protease inhibitor and zymogen: coagulation factor X cleaves the Arg393-Ser394 bond in a reactive centre loop of antithrombin in the presence of heparin.Prothrombotic SERPINC1 gene polymorphism may affect heparin sensitivity among different ethnicities of Chinese patients receiving heart surgery.Effect of covalent antithrombin-heparin complex on developmental mechanisms in the lung.
P2860
Q24561731-185D0136-FC2A-4D73-BD5E-1DD7A46FBA16Q27682019-7E874299-1A58-4D39-B2CB-CDC2AFD8AE0CQ28299898-76E9E6F3-F82E-45AF-BF09-55217A4F097EQ30573078-5AD09BEB-943B-4D16-BD1A-5C600DA3043DQ33423030-D49BCE91-8C14-4273-AA0F-50296FBA68D1Q33848336-3E11AB11-7079-4BD2-9C83-07CD2F43924CQ34168531-79DEB610-8BC0-4ADB-B0E0-B216A42CFDAAQ34268861-E48193C6-A6DA-473F-9541-CA4015745DA4Q35543249-07195617-7C5D-4B8C-B05D-1F6BF549032CQ35824673-E547052D-430D-46FB-B0E2-1491D21B3825Q36700767-AEFC8D6A-40B3-4B8F-8FFD-FBA9AFB3220CQ37654381-028C800A-54C1-472D-973C-0F5963B5E191Q37997628-93B6B8BC-4CD7-467D-BFA7-5DD79BF77EEBQ38294435-22EC3794-B4AA-4D27-84CA-418A904562C1Q38296443-F5C72B08-80BE-4A8D-9524-83DC68DE129CQ38298816-5296CD37-3504-4415-ABB8-76E4218FB1F2Q38338348-0D1A5D5A-62C6-45E7-BD84-1C02E13783B3Q38818678-3CB67FEE-FB5C-4E29-9EF8-AC2B349B63BDQ40337083-C3023006-C6E3-4F15-B20A-4A5866456DEDQ40810671-4A32B94A-5C08-4FD9-B928-0FC325E4065CQ40928849-23AF76F5-D37E-4330-BBF4-2EBBC9FFB6E7Q40938710-C23ECE79-71EE-47DD-9235-D862089710A9Q41865639-B5279A0D-EC45-46A5-B056-81E7FF2AD1F8Q42159081-AE500D87-F254-4151-A1CE-61AB3D710558Q43754806-4906F1E3-2C3E-4958-901B-3835978A75BBQ43821727-FE9EDF8D-1F4F-49B3-84D3-BDE4644B2FE8Q47220570-B4715E9D-A9CE-4C9C-BAB9-0D2A4B9193BFQ47834832-C2A4358B-2889-47B4-BDCF-2F2631DA60FCQ51943851-5A152D01-2CAA-4478-AF1B-0B1F1AFFD5FB
P2860
Regulation of thrombin activity by antithrombin and heparin.
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Regulation of thrombin activity by antithrombin and heparin.
@ast
Regulation of thrombin activity by antithrombin and heparin.
@en
Regulation of thrombin activity by antithrombin and heparin.
@nl
type
label
Regulation of thrombin activity by antithrombin and heparin.
@ast
Regulation of thrombin activity by antithrombin and heparin.
@en
Regulation of thrombin activity by antithrombin and heparin.
@nl
prefLabel
Regulation of thrombin activity by antithrombin and heparin.
@ast
Regulation of thrombin activity by antithrombin and heparin.
@en
Regulation of thrombin activity by antithrombin and heparin.
@nl
P356
P1476
Regulation of thrombin activity by antithrombin and heparin.
@en
P2093
P304
P356
10.1055/S-2007-1001928
P577
1994-01-01T00:00:00Z